Clinical Trial Update: A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 1/2 study of the combination of TQ05105 tablets and TQB3617 capsules in patients with myelofibrosis; the trial is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Drugs mentioned

• TQ05105
• TQB3617

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Myelofibrosis | Phase 1, Phase 2 | Status: RECRUITING